Literature DB >> 2660099

In vitro transcription analysis of the role of flanking sequence on the DNA sequence specificity of adriamycin.

H Trist1, D R Phillips.   

Abstract

An in vitro transcription assay has been used to define twelve high occupancy transcriptional blockage sites in 260 bp of heterogenous DNA on three promoter-containing DNA fragments. Transcription proceeded to immediately upstream of CpA sequences in nine of these sites, and this defines the most preferred intercalation site as CpA. In almost all cases, this sequence was flanked by T on the 5' end. The consensus sequence for the highest affinity Adriamycin site is therefore 5'-TCA, with some evidence for preference of AT base pairs flanking both ends of this trinucleotide [i.e., (t)TCA(a.t)(a.t)]. In contrast, lower occupancy CpA sites were flanked on the 5' end by a GC base pair, with a preference for up to three GC base pairs on the 3' end. The low affinity consensus sequence is therefore (G.C)CA(g.c)(g.c)(g.c).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2660099      PMCID: PMC317849          DOI: 10.1093/nar/17.10.3673

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  27 in total

Review 1.  Protein-nucleic acid interactions in transcription: a molecular analysis.

Authors:  P H von Hippel; D G Bear; W D Morgan; J A McSwiggen
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

2.  Interactions of molecules with nucleic acids. VII. Intercalation and T.A specificity of daunomycin in DNA.

Authors:  D D Newlin; K J Miller; D F Pilch
Journal:  Biopolymers       Date:  1984-01       Impact factor: 2.505

3.  Dissociation of polydeoxynucleotide-daunomycin complexes.

Authors:  M Grant; D R Phillips
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

4.  Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin.

Authors:  V H DuVernay; J A Pachter; S T Crooke
Journal:  Biochemistry       Date:  1979-09-04       Impact factor: 3.162

5.  The nucleotide sequence of the lactose messenger ribonucleic acid transcribed from the UV5 promoter mutant of Escherichia coli.

Authors:  N M Maizels
Journal:  Proc Natl Acad Sci U S A       Date:  1973-12       Impact factor: 11.205

6.  Adriamycin and daunorubicin bind in a cooperative manner to deoxyribonucleic acid.

Authors:  D E Graves; T R Krugh
Journal:  Biochemistry       Date:  1983-08-02       Impact factor: 3.162

7.  The interaction of daunomycin with polydeoxynucleotides.

Authors:  D R Phillips; A DiMarco; F Zunino
Journal:  Eur J Biochem       Date:  1978-04-17

8.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

9.  Molecular structure of an anticancer drug-DNA complex: daunomycin plus d(CpGpTpApCpG).

Authors:  G J Quigley; A H Wang; G Ughetto; G van der Marel; J H van Boom; A Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  A theoretical investigation on the sequence selective binding of daunomycin to double-stranded polynucleotides.

Authors:  K X Chen; N Gresh; B Pullman
Journal:  J Biomol Struct Dyn       Date:  1985-12
View more
  5 in total

1.  Hydropathic analysis of the free energy differences in anthracycline antibiotic binding to DNA.

Authors:  Derek J Cashman; J Neel Scarsdale; Glen E Kellogg
Journal:  Nucleic Acids Res       Date:  2003-08-01       Impact factor: 16.971

2.  An in vitro transcription assay for probing drug-DNA interactions at individual drug sites.

Authors:  D R Phillips; C M Cullinane; D M Crothers
Journal:  Mol Biotechnol       Date:  1998-08       Impact factor: 2.695

3.  DNA sequence specificity of mitoxantrone.

Authors:  C Panousis; D R Phillips
Journal:  Nucleic Acids Res       Date:  1994-04-25       Impact factor: 16.971

4.  The interaction of Fe(III), adriamycin and daunomycin with nucleotides and DNA and their effects on cell growth of fibroblasts (NIH-3T3).

Authors:  I Di Liegro; A Cestelli; B F Matzanke; E Bill; A X Trautwein
Journal:  Biometals       Date:  1996-04       Impact factor: 2.949

Review 5.  Polymeric Nanocarriers: A Transformation in Doxorubicin Therapies.

Authors:  Kamila Butowska; Anna Woziwodzka; Agnieszka Borowik; Jacek Piosik
Journal:  Materials (Basel)       Date:  2021-04-22       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.